Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

SNY, BMY, REGN and others ramp up 2025 dealmaking as pharma/biotech giants chase innovation across key growth areas.

Breakingviews provides financial professionals with unique agenda-setting insight on the major financial news stories as they ...

The UK Financial Conduct Authority teams up with Nvidia to launch a powerful AI sandbox, giving financial firms access to ...

Oil prices dipped slightly on weak Chinese economic data, but broader market sentiment remains buoyant ahead of crucial ...

Mr. Roberts and Mr. Moss will help guide Anteris through its next phase of growth, with the upcoming global pivotal PARADIGM study in 3Q2025 towards the ultimate U.S. and EMA licensure of the DurAVR ® ...